Find clinical trials for Lymphoma in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Cincinnati, OH, USA:
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Cincinnati, Ohio, United States and 66 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Cincinnati, Ohio, United States and 59 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Cincinnati, Ohio, United States of America and 70 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Cincinnati, Ohio, United States and 215 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Cincinnati, Ohio, United States and 94 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Cincinnati, Ohio, United States of America and 226 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Cincinnati, Ohio, United States of America and 33 other locations
of KT-333 in Adult patients with Relapsed or Refractory (R/R) Lymphomas, Large Granular Lymphocytic Leukemia (LGL-L), T-cell prolymphocytic ...
Phase 1
Cincinnati, Ohio, United States and 12 other locations
The participants of this study would have relapsed/refractory follicular lymphoma.Follicular lymphoma is a type of blood cancer. It...
Phase 3
Cincinnati, Ohio, United States and 171 other locations
This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal